The DOI matches its Crossref record.
Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice
Abstract
Objective. To define the true risk of hydroxychloroquine (HCQ) retinal toxicity by studying the largest single group yet evaluated. Methods. Retrospective chart review of all patients in the Kaiser Permanente Medical Care Program, Southern California Region, who had HCQ prescriptions filled from 1991 through 1993 (1,556 patients in 11 medical centers). Of 1,207 charts of patients who took HCQ and had documented ophthalmologic examinations, initial screening identified 21 charts (1.7%) that indicated possible HCQ toxicity. Results. We identified 1 patient with definite toxicity (1 of 1,207; 0.08%) and 5 other patients with indeterminate but probable toxicity (5 of 1,207; 0.4%). The incidence of definite HCQ retinal toxicity in patients treated with HCQ at <6.5 mg/kg/day was 0. Conclusion. In HCQ‐treated patients whose renal function is normal, routine ophthalmic screening is not indicated if the daily dosage is <6.5 mg/kg. In patients whose daily dosage is >6.5 mg/kg or who have taken HCQ continuously for > 10 years, annual screening may be appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Lyons, J. S., & Mieler, W. F. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.11.017 · Cited by 710
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Melles, R. B., & Marmor, M. F. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.3459 · Cited by 680
An update of the etiology and management of xerostomia
Porter, S. R., Scully, C., & Hegarty, A. M. (2004) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2003.07.010 · Cited by 378
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy
Marmor, M. F., Carr, R. E., Easterbrook, M., Farjo, A. A., & Mieler, W. F. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01168-5 · Cited by 371
Pasquier, B. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2104-y · Cited by 329
Wolfe, F., & Marmor, M. F. (2010) · Arthritis Care & Research · doi:10.1002/acr.20133 · Cited by 323
New concepts in antimalarial use and mode of action in dermatology
Kalia, S., & Dutz, J. P. (2007) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2007.00131.x · Cited by 257
The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine
Mavrikakis, I., Sfikakis, P. P., Mavrikakis, E., Rougas, K., Nikolaou, A., Kostopoulos, C., & Mavrikakis, M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00409-3 · Cited by 256
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Petri, M., Elkhalifa, M., Li, J., Magder, L. S., & Goldman, D. W. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41121 · Cited by 143
Hydroxychloroquine-related retinal toxicity
Ding, H. J., Denniston, A. K., Rao, V. K., & Gordon, C. (2016) · Rheumatology · doi:10.1093/rheumatology/kev357 · Cited by 100
Metadata
- Authors
- Levy, G. D., Munz, S. J., Paschal, J., Cohen, H. B., Pince, K. J., & Peterson, T.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-08
- Volume
- 40
- Issue
- 8
- Pages
- 1482-1486
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2136096562
- Cited by
- 250
- References
- 0
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.